Hextar Healthcare Berhad Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chin Khoo
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 11.5yrs |
CEO ownership | 0.005% |
Management average tenure | no data |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Unpleasant Surprises Could Be In Store For Hextar Healthcare Berhad's (KLSE:HEXCARE) Shares
Nov 06Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking
Dec 18The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing
Aug 30We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger
May 27Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)
Feb 26Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?
Nov 17If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late
May 11What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?
Apr 12Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 02Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today
Feb 09Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive
Jan 22How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?
Jan 04If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today
Dec 17Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?
Dec 02Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?
Nov 18What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?
Jul 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -RM 52m |
Jun 30 2024 | n/a | n/a | -RM 58m |
Mar 31 2024 | n/a | n/a | -RM 61m |
Dec 31 2023 | n/a | n/a | -RM 64m |
Sep 30 2023 | n/a | n/a | -RM 74m |
Jun 30 2023 | n/a | n/a | -RM 69m |
Mar 31 2023 | n/a | n/a | -RM 61m |
Dec 31 2022 | n/a | n/a | -RM 56m |
Sep 30 2022 | n/a | n/a | RM 10m |
Jun 30 2022 | n/a | n/a | RM 39m |
Mar 31 2022 | n/a | n/a | RM 102m |
Dec 31 2021 | RM 1m | RM 1m | RM 186m |
Sep 30 2021 | n/a | n/a | RM 236m |
Jun 30 2021 | n/a | n/a | RM 250m |
Mar 31 2021 | n/a | n/a | RM 208m |
Dec 31 2020 | RM 1m | RM 1m | RM 131m |
Sep 30 2020 | n/a | n/a | RM 76m |
Jun 30 2020 | n/a | n/a | RM 39m |
Mar 31 2020 | n/a | n/a | RM 19m |
Dec 31 2019 | RM 943k | RM 943k | RM 11m |
Sep 30 2019 | n/a | n/a | RM 11m |
Jun 30 2019 | n/a | n/a | RM 10m |
Mar 31 2019 | n/a | n/a | RM 10m |
Dec 31 2018 | RM 613k | RM 613k | RM 9m |
Compensation vs Market: Insufficient data to establish whether Chin's total compensation is reasonable compared to companies of similar size in the MY market.
Compensation vs Earnings: Chin's compensation has been consistent with company performance over the past year.
CEO
Chin Khoo (65 yo)
11.5yrs
Tenure
Mr. Chin Leng Khoo has been Group Managing Director and Director of Hextar Healthcare Berhad (formerly known as Rubberex Corporation (M) Berhad) since July 1, 2013 and served as its Financial Manager. Mr....
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Group MD & Director | 11.5yrs | no data | 0.0050% MYR 9.6k | |
Non-Independent Executive Director | 3.4yrs | no data | no data | |
Independent Non-Executive Director | 1.7yrs | RM 34.00k | no data | |
Independent & Non Executive Chairman | 3.4yrs | RM 66.00k | no data | |
Independent Non-Executive Director | 2yrs | RM 55.00k | no data | |
Independent Non-Executive Director | 2yrs | RM 57.00k | no data |
2.7yrs
Average Tenure
65yo
Average Age
Experienced Board: HEXCARE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 05:47 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hextar Healthcare Berhad is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Seong Chun Lim | RHB Investment Bank |